Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 1, 1999, Pages 33-41

  Massad, L Stewart ^a,j   Riester, Katherine A ^b   Anastos, Kathryn M ^c   Fruchter, Rachel G ^d   Palefsky, Joel M ^e   Burk, Robert D ^f   Burns, David ^g   Greenblatt, Ruth M ^e   Muderspach, Laila I ^h   Miotti, Paolo ⁱ  

^a RUSH MEDICAL COLLEGE   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^j Jr Hospital of Cook County   (United States)

more..

Author keywords

Cytology; HIV; Screening; Squamous intraepithelial lesion

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION;

EID: 0033135498     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-199905010-00005     Document Type: Article

References (46)

1. Rosenberg PS. Scope of the AIDS epidemic in the United States. Science 1995;270:1372-5.
2. Centers for Disease Control. HIV/AIDS Surveill Rep 1996;8:12.
3. Centers for Disease Control. HIV/AIDS Surveill Rep 1997;9:8.
4. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993;71:402-6.
5. Schafer A, Friedmann W, Mielke M, Schwartlander B, Koch MA. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991;164: 593-9.
6. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269:729-30.
7. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 1989:261:737-43.
8. Centers for Disease Control. 1997 USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWK Morb Mortal Wkly Rep 1997;46:26.
9. Marte C, Kelly P, Cohen M, et al. Papanicolaou smear abnormali-ties in ambulatory care sites for women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1992;166:1232-7.
10. Johnstone FD, McGoogan E, Smart GE, Brettle RP, Prescott RJ. A population-based, controlled study of the relation between HIV infection and cervical neoplasia. Br J Obstet Gynecol 1994;101: 986-91.
11. Korn AP, Autry M, DeRemer PA, Tan W. Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:401-4.
12. Maiman M, Fruchter RG, Sedlis A, et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the Human Immunodeficiency Virus. Gynecol Oncol 1998;68:233-9.
13. Six C, Heard I, Bergeron C, et al. Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 1998;12:1047-56.
14. Barkan SE, Melnick SL, Martin-Preston S, et al. The Women's Interagency HIV Study. Epidemiology 1998;9:117-25.
15. Tachezy R, Van Ranst MA, Cruz Y, Burk RD. Analysis of short novel human papillomavirus sequences. Biochem Biophys Res Commun 1994;204:820-7.
16. Revets H, Marissens D, De Wit S, et al. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV Monitor, and QUANTIPLEX HIV RNA Assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:1058-64.
17. Kurman RJ, Solomon D. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. New York: Springer-Verlag, 1994.
18. Rothman KJ. Modern Epidemiology. Boston: Little, Brown, 1986.
19. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
20. Ho DH. Viral counts count in HIV infection. Science 1996;272: 1124-5.
21. Conti M, Agarossi A, Parazzini F, et al. HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers. Gynecol Oncol 1993;49:344-8.
22. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7.
23. Wright TC, Richart RM. Role of human papillomavirus in the pathogenesis of genital tract warts and cancer. Gynecol Oncol 1990;37:151-64.
24. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
25. Johnson JC, Burnett AF, Willet GD, Young MA, Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992;70:321-7.
26. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:205-11.
27. Petry KU, Kochel H, Bode U, et al. Human papillomavirus is associated with the frequent detection of warty and basaloid highgrade neoplasia of the vulva and cervical neoplasia among immunocompromised women. Gynecol Oncol 1996;60:30-4.
28. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TF, Wright TC. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-9.
29. Klein RS, Ho GYF, Vermund SH, Fleming I, Burk RD. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for Human Immunodeficiency Virus infection. J Infect Dis 1994;170:1404-9.
30. Porreco R, Penn I, Droegemueller W, Greer B, Makowski E. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol 1975;45:359-64.
31. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early Human Immunodeficiency Virus Type 1 infection. N Engl J Med 1997;337:1267-74.
32. Vernon SD, Hart CE, Reeves WC, Icenogle JP. The HlV-1 tat protein enhances E2-dependent human papillomavirus transmission. Virus Res 1993;27:133-45.
33. Nuovo GJ, Forde A, MacConnell P, Fahrenwald R. In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am J Pathol 1993;143:40-8.
34. Cox JT, Schiffman MH, Winzelberg AJ, Patterson JM. An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet Gynecol 1992;80:389-95.
35. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-10.
36. Wright TC, Moscarelli RD, Dole P, Ellerbrock TV, Chiasson MA, Vandevanter N. Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet Gynecol 1996;87:515-9.
37. Bigrigg MA, Codling BW, Pearson P, Read MD, Swingler GR. Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit. Lancet 1990;336:229-31.
38. Spitzer M, Chernys AE, Seltzer VL. The use of large-loop excision of the transformation zone in an inner-city population. Obstet Gynecol 1993;82:731-5.
39. Maiman M, Tarricone N, Vieira J, Suarez J, Serur E, Boyce JG. Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstet Gynecol 1991;78:84-8.
40. Adachi A, Fleming I, Burk RD, Ho GY, Klein RS. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome. Obstet Gynecol 1993;81:372-7.
41. Boardman LA, Peipert JF, Cooper AS, Cu-Uvin S, Flanigan T, Raphael SI. Cytologic-histologic discrepancy in human immunodeficiency virus-positive women referred to a colposcopy clinic. Obstet Gynecol 1994;84:1016-20.
42. Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338-44.
43. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1992;84:394-8.
44. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993;82:578-85.
45. Hildesheim A, Schiffmen MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
46. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-9.